Lee Danner & Bass Inc Novartis Ag Transaction History

Lee Danner & Bass Inc

  • $1.36 Billion
  • Q3 2025

A detailed history of Lee Danner & Bass Inc transactions in Novartis Ag stock. As of the latest transaction made, Lee Danner & Bass Inc holds 6,959 shares of NVS stock, worth $915,456. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,959
Previous 7,323 4.97%
Holding current value
$915,456
Previous $886,000 0.68%
% of portfolio
0.07%
Previous 0.07%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025
SELL
$113.5 - $129.73 $41,314 - $47,221
-364 Reduced 4.97%
6,959 $892,000
Q2 2025

Jul 31, 2025
SELL
$101.96 - $121.01 $33,035 - $39,207
-324 Reduced 4.24%
7,323 $886,000
Q1 2025

Apr 29, 2025
SELL
$97.14 - $115.57 $15,348 - $18,260
-158 Reduced 2.02%
7,647 $852,000
Q4 2024

Feb 11, 2025
BUY
$96.78 - $117.18 $755,367 - $914,589
7,805 New
7,805 $759,000
Q3 2024

Oct 30, 2024
SELL
$106.13 - $120.89 $2,653 - $3,022
-25 Reduced 0.32%
7,805 $898,000
Q3 2023

Oct 27, 2023
SELL
$94.73 - $105.13 $14,209 - $15,769
-150 Reduced 1.88%
7,830 $798,000
Q2 2023

Jul 31, 2023
SELL
$92.52 - $104.91 $3,053 - $3,462
-33 Reduced 0.41%
7,980 $805,000
Q3 2022

Oct 31, 2022
SELL
$74.61 - $87.26 $7,461 - $8,726
-100 Reduced 1.23%
8,013 $609,000
Q2 2022

Jul 25, 2022
BUY
$80.52 - $93.75 $24,156 - $28,125
300 Added 3.84%
8,113 $686,000
Q1 2022

Apr 27, 2022
SELL
$80.11 - $90.62 $68,173 - $77,117
-851 Reduced 9.82%
7,813 $686,000
Q4 2021

Jan 27, 2022
SELL
$79.7 - $88.13 $3,985 - $4,406
-50 Reduced 0.57%
8,664 $758,000
Q2 2021

Jul 27, 2021
SELL
$85.24 - $94.15 $6,393 - $7,061
-75 Reduced 0.85%
8,714 $795,000
Q4 2020

Feb 09, 2021
SELL
$78.07 - $94.43 $2,810 - $3,399
-36 Reduced 0.41%
8,789 $830,000
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $16,428 - $18,200
-200 Reduced 2.22%
8,825 $767,000
Q2 2020

Aug 10, 2020
SELL
$80.93 - $91.1 $22,741 - $25,599
-281 Reduced 3.02%
9,025 $788,000
Q1 2020

May 04, 2020
SELL
$70.67 - $99.01 $50,529 - $70,792
-715 Reduced 7.14%
9,306 $767,000
Q4 2019

Feb 13, 2020
SELL
$84.35 - $95.37 $6,073 - $6,866
-72 Reduced 0.71%
10,021 $949,000
Q3 2019

Oct 30, 2019
BUY
$85.54 - $94.26 $598 - $659
7 Added 0.07%
10,093 $877,000
Q2 2019

Jul 30, 2019
SELL
$75.4 - $92.8 $7,540 - $9,280
-100 Reduced 0.98%
10,086 $921,000
Q4 2018

Jan 29, 2019
BUY
$73.66 - $82.02 $69,977 - $77,919
950 Added 10.29%
10,186 $874,000
Q3 2018

Nov 06, 2018
SELL
$66.94 - $77.43 $21,956 - $25,397
-328 Reduced 3.43%
9,236 $796,000
Q2 2018

Nov 02, 2018
BUY
$64.91 - $73.36 $25,964 - $29,344
400 Added 4.36%
9,564 $722,000
Q2 2018

Aug 06, 2018
SELL
$64.91 - $73.36 $25,964 - $29,344
-400 Reduced 4.18%
9,164 $769,000
Q1 2018

May 02, 2018
SELL
$70.39 - $84.15 $7,672 - $9,172
-109 Reduced 1.13%
9,564 $773,000
Q3 2017

Oct 27, 2017
BUY
$74.14 - $77.27 $717,156 - $747,432
9,673
9,673 $830,000

Others Institutions Holding NVS

# of Institutions
1,599
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Lee Danner & Bass Inc Portfolio

Follow Lee Danner & Bass Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lee Danner & Bass Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email